These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 6662867

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Predictions of stability in pharmaceutical preparations XIX: Stability evaluation and bioanalysis of clofibric acid esters by high-pressure liquid chromatography.
    Garrett ER, Gardner MR.
    J Pharm Sci; 1982 Jan; 71(1):14-25. PubMed ID: 7057373
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Diisopropylfluorophosphate increases clofibric acid clearance: supporting evidence for a futile cycle.
    Rowe BJ, Meffin PJ.
    J Pharmacol Exp Ther; 1984 Jul; 230(1):237-41. PubMed ID: 6747828
    [Abstract] [Full Text] [Related]

  • 6. High-performance liquid chromatographic assay for the simultaneous determination of ethyl clofibrate and clofibric acid in plasma. Evaluation of plasma stability of ethyl clofibrate polylactic nanocapsules in human and rat plasmas.
    Barra J, Taburet AM, Jardel A, Fessi H, Puisieux F.
    J Chromatogr B Biomed Appl; 1994 Nov 04; 661(1):178-82. PubMed ID: 7866548
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Plasmolysis, red blood cell partitioning, and plasma protein binding of etofibrate, clofibrate, and their degradation products.
    Altmayer P, Garrett ER.
    J Pharm Sci; 1983 Nov 04; 72(11):1309-18. PubMed ID: 6644594
    [Abstract] [Full Text] [Related]

  • 14. [Hypolipemic effect of amino acid derivatives of clofibric acid].
    Wójcicki J, Samochowiec L, Gawrońska-Szklarz B, Kwapiszewski W, Borkowski L.
    Acta Pol Pharm; 1985 Nov 04; 42(3):305-8. PubMed ID: 4096253
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Activation of hypolipidaemic drugs to acyl-coenzyme A thioesters.
    Bronfman M, Amigo L, Morales MN.
    Biochem J; 1986 Nov 01; 239(3):781-4. PubMed ID: 3827829
    [Abstract] [Full Text] [Related]

  • 19. Studies with etofibrate in the rat. Part I: Effects on glycerol, free fatty acid and triacylglycerol metabolism.
    Herrera E, Lasunción MA, Castro M, Gómez-Coronado D, Martín A, Quack G.
    Biochim Biophys Acta; 1988 Nov 04; 963(1):42-52. PubMed ID: 3179329
    [Abstract] [Full Text] [Related]

  • 20. Disposition of etofibrate, clofibric and nicotinic acid esters, and their products in dogs.
    Garrett ER, Altmayer P.
    J Pharm Sci; 1985 Mar 04; 74(3):295-9. PubMed ID: 4009437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.